Back

Study the dynamics of behavioral and biochemical parameters in the PARK2-knock-out mice model of Parkinson's disease

Emelianova, E.; Averina, O.; Permyakov, O. A.; Priymak, A. V.; Emelianova, M. A.; O. Grigoryeva, O. O.; Garmash, S. A.; Sergiev, P. V.; Frolova, O. U.; Kianitsa, K. E.; Savitskiy, V. S.; Lovat, M. L.

2026-03-05 neuroscience
10.64898/2026.03.02.709182 bioRxiv
Show abstract

BackgroundParkinsons disease (PD) is a progressive chronic neurodegenerative disease. The PARK2 gene encoding the Parkin protein accounts for approximately half of early-onset autosomal recessive PD cases in humans. ObjectiveThe aim of this work was to study the effect of the PARK2 gene knockout in mice on the dynamics of behavioral and biochemical parameters of PD. MethodsThe study was performed on C57BL/6-line mice aged from 4 months to 1.5 years: wild type (park2 +/+), heterozygotes (park2 +/-) and homozygotes (park2 -/-) knocked out by the PARK2 using CRISPR-Cas9. The open field test, the Porsolt forced swimming test, the grid-walk test, the beam-walking test, the elevated plus maze test, the accelerating rotarod test were used to assess the behavioral phenotype. Measurement of the concentration of bioamines and their metabolites by HPLC and evaluation of the amount of tyrosine hydroxylase, BDNF and GDNF by Western Blot were used to study the biochemical signs of PD. ResultsPark2 -/- mice begin to show signs of decreased motor activity no earlier than at 4 months of life. At 12 months of life, it was shown only a decrease in the level of the mature isoform of GDNF and an increase in the number of immature isoforms in the frontal cortex and striatum were revealed. ConclusionThe data obtained indicates a different age dynamic of the condition of mice associated with the PARK2 knockout. However, no pronounced specific manifestations of PD in human were found in park2 -/- mice.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 12%
14.9%
2
Parkinsonism & Related Disorders
21 papers in training set
Top 0.1%
10.5%
3
Scientific Reports
3102 papers in training set
Top 15%
6.6%
4
Movement Disorders
62 papers in training set
Top 0.4%
3.7%
5
Frontiers in Neurology
91 papers in training set
Top 1%
3.7%
6
Frontiers in Aging Neuroscience
67 papers in training set
Top 1%
2.7%
7
Neuroscience Letters
28 papers in training set
Top 0.2%
2.2%
8
ACS Chemical Neuroscience
60 papers in training set
Top 0.9%
2.0%
9
International Journal of Molecular Sciences
453 papers in training set
Top 7%
1.8%
10
npj Parkinson's Disease
89 papers in training set
Top 0.7%
1.8%
11
Journal of Neurology
26 papers in training set
Top 0.6%
1.7%
50% of probability mass above
12
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.5%
13
Experimental Neurology
57 papers in training set
Top 0.7%
1.5%
14
Molecular Neurobiology
50 papers in training set
Top 0.4%
1.5%
15
Frontiers in Neuroscience
223 papers in training set
Top 4%
1.5%
16
BMC Neurology
12 papers in training set
Top 0.5%
1.4%
17
Journal of Parkinson's Disease
13 papers in training set
Top 0.3%
1.2%
18
eneuro
389 papers in training set
Top 7%
1.0%
19
Pharmacological Research
15 papers in training set
Top 0.2%
0.9%
20
Cells
232 papers in training set
Top 5%
0.9%
21
Cureus
67 papers in training set
Top 4%
0.9%
22
Journal of Medical Virology
137 papers in training set
Top 3%
0.9%
23
Brain and Behavior
37 papers in training set
Top 1%
0.9%
24
Brain Sciences
52 papers in training set
Top 2%
0.8%
25
Neurobiology of Disease
134 papers in training set
Top 4%
0.8%
26
Journal of Alzheimer’s Disease
39 papers in training set
Top 1.0%
0.8%
27
PeerJ
261 papers in training set
Top 13%
0.8%
28
Heliyon
146 papers in training set
Top 5%
0.8%
29
Biomedicines
66 papers in training set
Top 3%
0.8%
30
Frontiers in Human Neuroscience
67 papers in training set
Top 2%
0.8%